Form 4: Korro Bio Director Katharine Knobil Acquires Stock Options

Director Katharine Knobil acquired stock options for 9,041 shares of Korro Bio, Inc. on August 26, 2024.

Summary

• Katharine Knobil, a director of Korro Bio, Inc., filed a Form 4 on August 28, 2024.
• The filing reports a transaction that occurred on August 26, 2024, where Ms. Knobil acquired stock options for 9,041 shares of Korro Bio common stock.
• The exercise price of the stock options is $49.
• The options vest in three equal annual installments starting August 26, 2024, contingent upon continued service.
• Following the transaction, Ms. Knobil directly owns derivative securities for 9,041 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's stock option grant, which is neither overtly positive nor negative.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedule of the options suggests a multi-year commitment from the director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in biotech companies like Korro Bio.
• Comparable companies such as CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics also utilize stock options as part of their executive compensation plans.
• The vesting schedule of three years is also typical in the industry, aligning executive incentives with long-term company performance.

Stakeholder Impact

• The acquisition of stock options by a director can positively influence shareholder sentiment, as it aligns the director's interests with those of the shareholders.

Key Dates